AGP Picks
View all

Bay State Times
Provided by AGP

Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 1, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Sep. 1, 2026

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire
AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer
Sep. 1, 2026

AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer

Indeterminate GlobeNewswire
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Sep. 1, 2026

Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep. 1, 2026

Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Jade Biosciences to Participate in Upcoming Conferences
Sep. 1, 2026

Jade Biosciences to Participate in Upcoming Conferences

Indeterminate GlobeNewswire
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
ElevateBio Appoints Steven Falcone as Chief Operating Officer
Sep. 1, 2026

ElevateBio Appoints Steven Falcone as Chief Operating Officer

Indeterminate GlobeNewswire
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep. 1, 2026

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
Sep. 1, 2026

Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
Sep. 1, 2026

Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences
Sep. 1, 2026

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

Indeterminate GlobeNewswire
Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP
Sep. 1, 2026

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Bay State Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.